1
Orphan Designations
0 approved, 1 designated
0
FDA Approvals
0
Active Trials
5
Rare Diseases
across 10 areas
0
News (30d)
Quiet
Hovid Berhad is a company with 1 orphan drug designation across 5 rare diseases. gene therapy candidates in 1 disease.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
| Disease | Drug(s) | Stage |
|---|---|---|
| CARASIL syndrome | palm tocotrienol complex | Des.TrialAppr. |
| HTRA1-related autosomal dominant cerebral small vessel disease | palm tocotrienol complex | Des.TrialAppr. |
| cathepsin a-related arteriopathy-strokes-leukoencephalopathy | palm tocotrienol complex | Des.TrialAppr. |
| cerebral arteriopathy with subcortical infarcts and leukoencephalopathy | palm tocotrienol complex | Des.TrialAppr. |
| retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations | palm tocotrienol complex | Des.TrialAppr. |
33% of portfolio targets high unmet need diseases
1
overlap in 2+ diseases
1/5
candidate diseases
0
avg importance: 0
0
affecting portfolio
33% of portfolio targets high unmet need diseases
1
overlap in 2+ diseases
1/5
candidate diseases
0
avg importance: 0
0
affecting portfolio